Table 2.
Protein array analysis
| PROTEIN | FOLD CHANGE |
|---|---|
| TIMP-1 | 5.61 |
| TIMP-2 | 4.88 |
| CNTF R alpha | 3.42 |
| Activin A | 2.2 |
| Fractalkine | 2.04 |
| CCR4 | 2.01 |
| MIP-3 alpha | 1.97 |
| CD106 | 1.97 |
| ICK | 1.88 |
| TGF-beta2 | 1.88 |
| TAL1A | 1.82 |
| IL-4 | 1.77 |
| CINC-3 | 1.68 |
| CINC-2 alpha/beta | 1.59 |
| GM-CSF | 1.57 |
| MCP-1 | 1.53 |
| GFR alpha-2 | 1.49 |
| IL-6 | 1.44 |
| beta-NGF | 1.43 |
| VEGF | 1.42 |
| Neuropilin-2 | 1.42 |
| CXCR4 | 1.41 |
| IL-1 beta | 1.4 |
| IL-10 | 1.37 |
| MuSK | 1.36 |
| CNTF | 1.36 |
| LIX | 1.32 |
| E-Selectin | 1.32 |
| IL-1 R6/IL-1 R rp2 | 1.31 |
| B7-1/CD80 | 1.3 |
| ACTH | 1.3 |
| MIP-1 alpha | 1.3 |
| IP-10 | 1.28 |
| Growth Hormone | 1.24 |
| GFR alpha-1 | 1.24 |
| MMP-13 | 1.22 |
| IL-1 alpha | 1.21 |
| PDGF-AA | 1.19 |
| RALT/MIG-6 | 1.15 |
| Adiponectin/Acrp30 | 1.14 |
| RAGE | 1.14 |
| BDNF | 1.14 |
| IL-13 | 1.12 |
| Prolactin R | 1.11 |
| Inuslin | 1.09 |
| MMP-2 | 1.09 |
| MMP-8 | 1.09 |
| basic-FGF | 1.08 |
| Orexin A | 1.03 |
| EG-VEGF/PK1 | 1.03 |
| Resistin | 1.03 |
| Fas/TNFRSF6 | 1.02 |
| Fas Ligand/TNFSF6 | 1 |
| Follostatin-like -1(FSL1) | 0.97 |
| ADFP | 0.97 |
| L-Selectin/CD62L | 0.96 |
| Leptin (OB) | 0.94 |
| RELM beta | 0.94 |
| Growth Hormone R | 0.93 |
| ICAM-1/CD54 | 0.93 |
| FGF-BP | 0.91 |
| IL-5 | 0.9 |
| Integrin alpha M beta 2 | 0.81 |
| TLR4 | 0.71 |
| IL-12/IL-23 p40 | 0.7 |
| TGF-beta3 | 0.68 |
| Ubiquitin | 0.58 |
| TIE-2 | 0.53 |
| TIMP-3 | 0.50 |
| TROY | 0.48 |
| AMPK alpha 1 | 0.43 |
| MIP-2 | 0.30 |
TGF-β1, beta-Catenin, CSK, EGFR, FADD, Hepassocin, IDE (Insulin Degrading Enzyme), IFN-gamma, IL-2, IL-3, MDC, MIF, NGFR, Osteopontin/SPP1, Thrombospondin, TNF-alpha, TRAIL, and VEGF-C were excluded from the final analysis, because the intensity of these proteins failed to reach the threshold-value calculated from the blank controls.